Sort
51,593 grants matching “hepatitis”
Linking fat metabolism to hepatic fibrosis
$515,670Sonia Michael Najjar · Ohio University Athens · R01 · FY2021 · DK
Linking fat metabolism to hepatic fibrosis
$515,670Sonia Michael Najjar · Ohio University Athens · R01 · FY2022 · DK
Studies on RNAi Based Delivery in Vivo
$515,649Mark A Kay · Stanford University · R01 · FY2014 · DK
Regulation of Sex Differences in Liver Metabolism
$515,633David J Waxman · Boston University (Charles River Campus) · R01 · FY2015 · DK
Critical Lipid Species in the Hepatovirus Lifecycle
$515,618Stanley M Lemon · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
$515,612Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2024 · CA
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
$515,560Arti Hurria · Beckman Research Institute/City Of Hope · R01 · FY2012 · AG
Project 2: Alpha-Emitter Radioimmunotherapy-Based Allografting to Cure Acute Leukemia and Myelodysplastic Syndrome
$515,540Brenda Marie Sandmaier · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
Role of Insulin Biosynthesis in Glucose Tolerance
$515,485Daniel T Stein · Albert Einstein College Of Medicine · R01 · FY2010 · DK
Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China
$515,458Scott L Letendre · University Of California, San Diego · R01 · FY2013 · MH
RESEARCH TRAINING CORE
$515,430Robert Anders · University Of Texas El Paso · P20 · FY2011 · MD
Arachidonate Products and CYP1A in Dioxin Toxicity
$515,338Arleen B. Rifkind · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · ES
Therapeutic targets in African-American youth with type 2 diabetes
$515,311Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Hepatic fat accumulation in nonalcoholic fatty liver disease: critical regulation by kisspeptin signaling
$515,309Moshmi M Bhattacharya · Rbhs-Robert Wood Johnson Medical School · R01 · FY2022 · DK
Trans-acting Factors Causing Cell Specific Gene Control
$515,303Kenneth S Zaret · University Of Pennsylvania · R37 · FY2010 · GM
Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity
$515,286Steven William Hetts · University Of California, San Francisco · R01 · FY2018 · CA
Identification of Novel Genes/Pathways That Regulate Atherogenesis
$515,277Yanqiao Zhang · Northeast Ohio Medical University · R01 · FY2020 · HL
Identification of Novel Genes/Pathways That Regulate Atherogenesis
$515,277Yanqiao Zhang · Northeast Ohio Medical University · R01 · FY2019 · HL
Identification of Novel Genes/Pathways That Regulate Atherogenesis
$515,277Yanqiao Zhang · Northeast Ohio Medical University · R01 · FY2021 · HL
Identification of Novel Genes/Pathways That Regulate Atherogenesis
$515,277Yanqiao Zhang · Northeast Ohio Medical University · R01 · FY2018 · HL
O-glycoproteins in the progression of liver disease
$515,257Radoslav Goldman · Georgetown University · R01 · FY2019 · CA
O-glycoproteins in the progression of liver disease
$515,257Radoslav Goldman · Georgetown University · R01 · FY2021 · CA
O-glycoproteins in the progression of liver disease
$515,257Radoslav Goldman · Georgetown University · R01 · FY2020 · CA
Organoid-guided Precision Hepatology for Steatohepatitis
$515,224Takanori Takebe · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · DK
Novel Role of Hepatic SEL1L-HRD1 ERAD in FGF21 Gene Transcription
$515,194Ling Qi · University Of Michigan At Ann Arbor · R01 · FY2021 · DK